Breaking News Instant updates and real-time market news.

SYBT

S.Y. Bancorp

$31.01

-0.35 (-1.12%)

04:55
12/04/18
12/04
04:55
12/04/18
04:55

S.Y. Bancorp management to meet with Stephens

Group Luncheon Meeting with Management will be held in New York on December 3 at 12:30 pm and in Philadelphia/Washington, D.C. on December 4.

  • 04

    Dec

SYBT S.Y. Bancorp
$31.01

-0.35 (-1.12%)

03/26/18
FIGP
03/26/18
UPGRADE
FIGP
Outperform
S.Y. Bancorp upgraded to Outperform from Market Perform at Fig Partners

TODAY'S FREE FLY STORIES

VBLT

VBL Therapeutics

$1.26

0.005 (0.40%)

07:06
11/14/19
11/14
07:06
11/14/19
07:06
Hot Stocks
VBL Therapeutics expects to begin NCI-sponsored trial of VB-111 by year-end »

An NCI-sponsored trial of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 21

    Nov

WMT

Walmart

$121.06

1.93 (1.62%)

07:06
11/14/19
11/14
07:06
11/14/19
07:06
Hot Stocks
Walmart reports Q3 U.S. SSS up 3.2% »

Q3 U.S. comp sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

MITO

Stealth Biotherapeutics

$7.20

0.35 (5.11%)

07:05
11/14/19
11/14
07:05
11/14/19
07:05
Earnings
Stealth Biotherapeutics reports Q3 EPS (4c), consensus (4c) »

"We're…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

BIIB

Biogen

$281.71

-9.67 (-3.32%)

, ALKS

Alkermes

$19.39

-0.5 (-2.51%)

07:05
11/14/19
11/14
07:05
11/14/19
07:05
Hot Stocks
MS Society asks Biogen, Alkermes to keep Vumerity price raises below inflation »

The National Multiple…

BIIB

Biogen

$281.71

-9.67 (-3.32%)

ALKS

Alkermes

$19.39

-0.5 (-2.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBLT

VBL Therapeutics

$1.26

0.005 (0.40%)

07:05
11/14/19
11/14
07:05
11/14/19
07:05
Hot Stocks
VBL Therapeutics expects cash to fund requirements for two years »

At September 30, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 21

    Nov

XCUR

Exicure

$2.45

-0.14 (-5.41%)

, AGN

Allergan

$181.56

-0.38 (-0.21%)

07:05
11/14/19
11/14
07:05
11/14/19
07:05
Hot Stocks
Exicure, Allergan subsidiary enter collaboration to find hair loss treatments »

Exicure (XCUR) announced…

XCUR

Exicure

$2.45

-0.14 (-5.41%)

AGN

Allergan

$181.56

-0.38 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBLT

VBL Therapeutics

$1.26

0.005 (0.40%)

07:05
11/14/19
11/14
07:05
11/14/19
07:05
Earnings
VBL Therapeutics reports Q3 EPS (14c), consensus (14c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 21

    Nov

WMT

Walmart

$121.06

1.93 (1.62%)

07:05
11/14/19
11/14
07:05
11/14/19
07:05
Earnings
Walmart reports Q3 adjusted EPS $1.16, consensus $1.09 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

TJX

TJX

$58.45

0.505 (0.87%)

, ROST

Ross Stores

$111.38

0.41 (0.37%)

07:04
11/14/19
11/14
07:04
11/14/19
07:04
Recommendations
TJX, Ross Stores, Burlington Stores, Nordstrom, Macy's analyst commentary  »

Guggenheim raises price…

TJX

TJX

$58.45

0.505 (0.87%)

ROST

Ross Stores

$111.38

0.41 (0.37%)

BURL

Burlington Stores

$199.23

-1.14 (-0.57%)

JWN

Nordstrom

$37.18

0.28 (0.76%)

M

Macy's

$16.06

-0.02 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 26

    Nov

LPTX

Leap Therapeutics

$1.17

-0.035 (-2.92%)

07:04
11/14/19
11/14
07:04
11/14/19
07:04
Earnings
Leap Therapeutics reports Q3 EPS (33c), consensus (33c) »

"The body of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIA

Viacom

$25.14

-0.615 (-2.39%)

, VIAB

Viacom

$22.04

-0.52 (-2.31%)

07:04
11/14/19
11/14
07:04
11/14/19
07:04
Earnings
Viacom reports Q4 adj. EPS 79c, consensus 75c »

Reports Q4 revenue…

VIA

Viacom

$25.14

-0.615 (-2.39%)

VIAB

Viacom

$22.04

-0.52 (-2.31%)

CBS

CBS

$36.84

-0.935 (-2.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 09

    Dec

FULC

Fulcrum Therapeutics

$8.40

0.405 (5.07%)

07:02
11/14/19
11/14
07:02
11/14/19
07:02
Hot Stocks
Fulcrum Therapeutics expects to file IND for FTX-6058 in mid-2020 »

n October 2019, Fulcrum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

FULC

Fulcrum Therapeutics

$8.40

0.405 (5.07%)

07:02
11/14/19
11/14
07:02
11/14/19
07:02
Hot Stocks
Fulcrum Therapeutics expects cash to fund requirements into 3Q21 »

As of September 30, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

TRIP

TripAdvisor

$30.83

-0.87 (-2.74%)

, GOOGL

Alphabet Class A

$1,296.00

-1.18 (-0.09%)

07:01
11/14/19
11/14
07:01
11/14/19
07:01
Recommendations
TripAdvisor, Alphabet Class A, Alphabet analyst commentary  »

TripAdvisor price target…

TRIP

TripAdvisor

$30.83

-0.87 (-2.74%)

GOOGL

Alphabet Class A

$1,296.00

-1.18 (-0.09%)

GOOG

Alphabet

$1,298.00

-0.77 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

  • 26

    Nov

FULC

Fulcrum Therapeutics

$8.40

0.405 (5.07%)

07:01
11/14/19
11/14
07:01
11/14/19
07:01
Earnings
Fulcrum Therapeutics reports Q3 EPS (97c), consensus ($2.98) »

"This past quarter,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

AMRN

Amarin

$21.49

0.55 (2.63%)

07:00
11/14/19
11/14
07:00
11/14/19
07:00
Hot Stocks
Amarin announces Nasdaq halts trading of company's shares »

Amarin announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

GOOS

Canada Goose

$34.81

-4.245 (-10.87%)

06:59
11/14/19
11/14
06:59
11/14/19
06:59
Recommendations
Canada Goose analyst commentary  »

Canada Goose price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBIV

VBI Vaccines

$0.56

-0.0091 (-1.60%)

06:58
11/14/19
11/14
06:58
11/14/19
06:58
Initiation
VBI Vaccines initiated  »

VBI Vaccines initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTOR

Meritor

$23.78

0.34 (1.45%)

06:57
11/14/19
11/14
06:57
11/14/19
06:57
Upgrade
Meritor rating change  »

Meritor upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LIN

Linde plc

$207.61

1.815 (0.88%)

06:57
11/14/19
11/14
06:57
11/14/19
06:57
Recommendations
Linde plc analyst commentary  »

Linde plc price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$84.76

0.63 (0.75%)

, AZN

AstraZeneca

$47.84

0.76 (1.61%)

06:56
11/14/19
11/14
06:56
11/14/19
06:56
Hot Stocks
Merck, AstraZeneca: FDA accepts NDA, grants priority review for selumetinib »

AstraZeneca (AZN) and…

MRK

Merck

$84.76

0.63 (0.75%)

AZN

AstraZeneca

$47.84

0.76 (1.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 07

    Dec

  • 10

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

XCUR

Exicure

$2.45

-0.14 (-5.41%)

06:56
11/14/19
11/14
06:56
11/14/19
06:56
Hot Stocks
Breaking Hot Stocks news story on Exicure »

Exicure Inc trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$21.49

0.55 (2.63%)

06:55
11/14/19
11/14
06:55
11/14/19
06:55
Hot Stocks
Breaking Hot Stocks news story on Amarin »

Amarin trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

XLNX

Xilinx

$93.33

-1.85 (-1.94%)

06:54
11/14/19
11/14
06:54
11/14/19
06:54
Conference/Events
Xilinx management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 20

    Nov

  • 06

    Jan

  • 28

    Jan

VCEL

Vericel

$18.80

-0.41 (-2.13%)

06:52
11/14/19
11/14
06:52
11/14/19
06:52
Conference/Events
Vericel management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.